tiprankstipranks
Trending News
More News >
Advertisement

ELCV - ETF AI Analysis

Compare

Top Page

ELCV

Eventide High Dividend ETF (ELCV)

Rating:69Neutral
Price Target:
ELCV, the Eventide High Dividend ETF, appears to be a solid-quality fund, supported by strong holdings like Amgen, Medtronic, and Royalty Pharma, which bring robust financial performance, growth potential, and income appeal. Additional strength comes from names like Prologis, Exxon Mobil, and Huntington Bancshares, which show healthy fundamentals and strategic progress, though sometimes at premium valuations. The main risks to the fund’s rating come from holdings such as Entergy and Home Depot, where high leverage, weaker technical trends, and cash flow concerns could weigh on future performance.
Positive Factors
Broad Sector Diversification
The fund spreads its investments across several sectors like energy, utilities, financials, health care, and technology, which helps reduce the impact if any one area of the market struggles.
Generally Strong Top Holdings
Most of the largest positions, including companies in real estate, utilities, retail, health care, and energy, have shown positive performance this year, supporting the ETF’s overall returns.
Positive Recent Performance
The ETF has delivered steady gains over the past month, three months, and year to date, suggesting its strategy has been working in the current market environment.
Negative Factors
High U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, which limits the benefits of international diversification and ties performance closely to the U.S. economy.
Above-Average Expense Ratio
The fund’s fee is on the higher side for an ETF, which means more of the returns are used to cover costs instead of going to investors.
Mixed Performance Among Top Holdings
While most major positions have done well, at least one significant holding has been weak this year, which can drag on overall performance if that continues.

ELCV vs. SPDR S&P 500 ETF (SPY)

ELCV Summary

The Eventide High Dividend ETF (ELCV) is an actively managed fund that focuses on U.S. companies that pay relatively high dividends, aiming to provide investors with a steady income stream. It doesn’t track a specific index, but spreads investments across many sectors, including energy, utilities, financials, and health care. Well-known holdings include Exxon Mobil and Home Depot. Someone might consider ELCV if they want regular dividend income plus some potential for long-term growth and diversification across industries. A key risk is that stock prices and dividend payments can go up or down with the overall market and the economy.
How much will it cost me?The Eventide High Dividend ETF (ELCV) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, focusing on selecting high-dividend stocks to maximize income and growth potential.
What would affect this ETF?The Eventide High Dividend ETF (ELCV) could benefit from stable or rising interest in dividend-paying stocks, particularly in sectors like Utilities and Energy, which are traditionally resilient during economic uncertainty. However, it may face challenges if interest rates rise significantly, as higher rates can make dividend-focused investments less attractive compared to fixed-income alternatives. Additionally, sector-specific risks, such as regulatory changes in Energy or Financials, could impact performance.

ELCV Top 10 Holdings

This U.S.-focused dividend fund leans heavily on energy and utilities, with Exxon Mobil and Williams Co helping to power recent gains as they ride strong earnings and steady cash flows. Real estate giant Prologis and pipeline player Enbridge add a stable, income-oriented backbone, while Amgen and Royalty Pharma give the portfolio a healthy dose of rising healthcare exposure. On the softer side, Home Depot looks more mixed, and Medtronic has been lagging lately, showing that not every income name is firing on all cylinders at the moment.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Prologis5.29%$8.86M$124.71B16.14%
76
Outperform
Entergy4.72%$7.89M$47.08B23.15%
66
Neutral
Williams Co4.28%$7.17M$90.47B22.72%
76
Outperform
Amgen4.07%$6.82M$188.63B11.07%
77
Outperform
Exxon Mobil3.92%$6.56M$659.02B36.46%
74
Outperform
Home Depot3.45%$5.78M$326.90B-6.36%
66
Neutral
Enbridge3.37%$5.63M$117.85B21.69%
Royalty Pharma3.13%$5.23M$26.27B37.05%
79
Outperform
Huntington Bancshares3.00%$5.02M$30.79B0.94%
80
Outperform
Medtronic2.83%$4.74M$111.53B-4.77%
80
Outperform

ELCV Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
28.63
Positive
100DMA
27.59
Positive
200DMA
26.65
Positive
Market Momentum
MACD
0.02
Positive
RSI
48.96
Neutral
STOCH
56.04
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ELCV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 29.24, equal to the 50-day MA of 28.63, and equal to the 200-day MA of 26.65, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 48.96 is Neutral, neither overbought nor oversold. The STOCH value of 56.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ELCV.

ELCV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$168.15M0.49%
69
Neutral
$606.65M0.50%
72
Outperform
$218.22M0.59%
68
Neutral
$151.40M0.35%
72
Outperform
$70.53M0.35%
71
Outperform
$27.61M0.45%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ELCV
Eventide High Dividend ETF
28.92
4.48
18.33%
FDV
Federated Hermes U.S. Strategic Dividend ETF
TBG
TBG Dividend Focus ETF
HIDV
AB US High Dividend ETF
FDIV
MarketDesk Focused U.S. Dividend ETF
DIVY
Sound Equity Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement